Education, Science, Technology, Innovation and Life
Open Access
Sign In
  1. Home
  2. Journals
  3. Transactions on Cancer
  4. Vol 6, Issue 1, 2025

Immunotherapy: Isolation and Detection of Exosomes of Natural Killer Cells

Download as PDF

DOI: 10.23977/tranc.2025.060108 | Downloads: 4 | Views: 171

Author(s)

Yunxin Zhang 1

Affiliation(s)

1 Singapore International School (Hong Kong), 23 Nam Long Shan Road, Aberdeen, Hong Kong, China

Corresponding Author

Yunxin Zhang

ABSTRACT

Natural killer (NK) cell-based immunotherapies show increasing research popularity in cancer treatment. With the ability to kill target cells in a non-MHC-restricted manner (Major Histocompatibility Complex), NK cells have drawn remarkable attention for their effectiveness and significance. In particular, exosome isolation and detection are crucial in clinical use because exosomes can serve as valuable biomarkers for examining diseases. Their ability to carry and transfer biomolecules makes them an effective tool that can provide the world with a deeper understanding of disease mechanisms and develop new therapies by harnessing the potential of exosomes. Moreover, NK cell-derived exosomes (NK-Exo) also have a significant effect on cancer treatment. They direct the immune system to generate effective antitumor immune responses, making them an adaptive therapy in treating cancer. In these cases, this research aims to suggest an optimal method to isolate and detect exosomes of NK cells, which are the critical first steps in employing NK-Exos into clinical applications. Isolating them by ultracentrifugation, observing them under fluorescence microscopy, and detecting protein markers in exosomes will surely allow us to understand the significance of exosomes in nuanced detail.

KEYWORDS

NK Cell Isolation; Cancer Cellular Immunotherapy; NK Cell-Derived Exosomes; Detection Method

CITE THIS PAPER

Yunxin Zhang, Immunotherapy: Isolation and Detection of Exosomes of Natural Killer Cells. Transactions on Cancer (2025) Vol. 6: 50-62. DOI: http://dx.doi.org/10.23977/tranc.2025.060108.

REFERENCES

[1] A. S. Alfawaz Altamimi et al., "Exosomes derived from natural killer cells: transforming immunotherapy for aggressive breast cancer," Med. Oncol. Northwood Lond. Engl., vol. 42, no. 4, p. 114, Mar. 2025, doi: 10.1007/s12032-025-02647-y.
[2] S. Kundu, L. Durkan, M. O’Dwyer, and E. Szegezdi, "Protocol for isolation and expansion of natural killer cells from human peripheral blood scalable for clinical applications," Biol. Methods Protoc., vol. 10, no. 1, p. bpaf015, 2025, doi: 10.1093/biomethods/bpaf015.
[3] Y. Deng et al., "Prospects and limitations of NK cell adoptive therapy in clinical applications," Cancer Metastasis Rev., vol. 44, no. 3, p. 57, Jun. 2025, doi: 10.1007/s10555-025-10273-3.
[4] J. Chu et al., "Natural killer cells: a promising immunotherapy for cancer," J. Transl. Med., vol. 20, no. 1, p. 240, May 2022, doi: 10.1186/s12967-022-03437-0.
[5] Y. Zhong and J. Liu, "Emerging roles of CAR-NK cell therapies in tumor immunotherapy: current status and future directions," Cell Death Discov., vol. 10, no. 1, p. 318, Jul. 2024, doi: 10.1038/s41420-024-02077-1.
[6] N. Dilsiz, "A comprehensive review on recent advances in exosome isolation and characterization: Toward clinical applications," Transl. Oncol., vol. 50, p. 102121, Dec. 2024, doi: 10.1016/j.tranon.2024.102121.

Subscription
E-Mail Alert
Most popular papers
Call for Special Issue
Publication Ethics & OA Statement
Plagiarism Policy
Contact Us
Downloads: 1109
Visits: 81986

Sponsors, Associates, and Links

All published work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright © 2016 - 2031 Clausius Scientific Press Inc. All Rights Reserved.